Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Multiple Sclerosis
100%
Therapeutic Approaches
100%
Diagnostic Approach
100%
Therapeutic Strategies
91%
Meta-analysis
66%
Vertigo
50%
Seizure Onset
50%
Anticoagulants
50%
Overanticoagulation
50%
Syncope
50%
Temporal Lobe Epilepsy
50%
Cerebral Cavernous Malformation
50%
Bench to Bedside
50%
Umbrella Review
50%
Clinical Aspects
50%
False Lateralization
50%
Diagnostic Accuracy
50%
Diabetic Peripheral Neuropathy
50%
Uveitis
50%
Comprehensive Evaluation
50%
Screening Test
50%
Corticosteroids
50%
Molecular Aspects
50%
Posterior Cortical Atrophy
50%
Posterior Reversible Encephalopathy Syndrome
50%
Alzheimer's Disease
50%
Alzheime's Disease
50%
Psychiatric Side Effects
50%
Stereoelectroencephalography
50%
Colombia
50%
Clinical Approach
41%
Ictal Onset
37%
Screening Tool
33%
Screening Method
33%
Neurological Complications
33%
Seizure
30%
Etiology
29%
Cavernoma
25%
Neuropsychiatric Symptoms
25%
Peripheral Vertigo
25%
Central Vertigo
25%
Atypical Presentation
20%
Neuroimaging
20%
Methodological Quality
16%
Diabetes
16%
Perception Study
16%
Single Test
16%
Peripheral Neuropathy
16%
Monofilament Test
16%
Early Diagnosis
16%
Medicine and Dentistry
Clinical Feature
62%
Screening Test
50%
Diagnostic Accuracy
50%
Diabetic Neuropathy
50%
Umbrella Review
50%
Posterior Cortical Atrophy
50%
Posterior Reversible Encephalopathy Syndrome
50%
Alzheimer's Disease
50%
Levetiracetam
50%
Corticosteroid
50%
Neurological Complication
33%
Neuropsychiatric Symptom
25%
Tissue Plasminogen Activator
20%
Independent Reviewer
16%
Clinician
16%
Neuropathy
16%
Meta-Analysis
16%
Vibration Sense
16%
Early Diagnosis
16%
Patient Population
16%
Health Care Cost
16%
Diabetes
16%
Systematic Review
16%
Morbidity
16%
Depressive Psychosis
12%
Cellular Mechanism
12%
Excitability
12%
Oxidative Stress
12%
Euphoria
12%
Cognitive Defect
12%
Mood Disorder
12%
Dysgraphia
12%
Degenerative Disease
12%
Adverse Event
12%
Clinical Trial
12%
Hippocampus
12%
Apraxia
12%
Inflammation
12%
Visual Acuity
11%
Cerebrovascular Disease
11%
Hypophysis Apoplexy
10%
Middle Cerebral Artery
10%
National Institutes of Health Stroke Scale
10%
Modified Rankin Scale
10%
Epileptic Seizure
5%
Retrospective Study
5%
Fatality
5%
Brain Edema
5%
Status Epilepticus
5%
Logistic Regression Analysis
5%
Neuroscience
Multiple Sclerosis
50%
Brain Ischemia
50%
Cerebrovascular Accident
50%
Diabetic Neuropathy
50%
Temporal Lobe Epilepsy
50%
Electroencephalogram
50%
Neuromyelitis Optica
50%
Cerebral Infarction
50%
Corticosteroid
50%
Brain Disease
50%
Ictal
37%
Meta-Analysis
25%
Neuropsychiatric Symptom
25%
Neuropathy
25%
Tissue Plasminogen Activator
25%
Systematic Review
25%
Cerebral Hemorrhage
18%
Euphoria
12%
Depressive Psychosis
12%
Cognitive Disorder
12%
Adverse Effect
12%
Excitability
12%
Mood Disorder
12%
Oxidative Stress
12%
Medial Frontal Gyrus
12%
Supplementary Motor Area
12%
Temporal Lobe
12%
Mesial Temporal Lobe Epilepsy
12%
Limbic System
12%
Middle Cerebral Artery
12%
Hippocampal Sclerosis
12%
Cerebral Cortex
12%
Intracranial Tumor
12%
Spinal Cord
12%
Brain Region
12%
Epileptogenicity
12%
Epilepsy
12%
Optic Nerve
11%
Visual Acuity
11%
Cerebrovascular Disease
11%
Quality of Life
8%
Comorbidity
8%
Nervous System Disorder
8%
Electric Shock
8%
Central Nervous System
5%
Headache
5%
Optic Neuritis
5%
Transverse Myelitis
5%
Serology
5%
Myelitis
5%
